First Annual National Lymphoma Awareness Week

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 9
Volume 5
Issue 9

LOS ANGELES, Calif--The first annual National Lymphoma Awareness Week, sponsored by the Lymphoma Research Foundation of America, is scheduled for October 13 to 19. Members of the Foundation will launch local awareness activities and educational events throughout the week to inform the public about lymphatic cancers.

LOS ANGELES, Calif--The first annual National Lymphoma AwarenessWeek, sponsored by the Lymphoma Research Foundation of America,is scheduled for October 13 to 19. Members of the Foundation willlaunch local awareness activities and educational events throughoutthe week to inform the public about lymphatic cancers.

Actress Jamie Lee Curtis serves as Honorary Chair for AwarenessWeek. Actress Tracy Nelson, daughter of the late singer Rick Nelson,is a Hodgkin's lymphoma survivor and acts as spokesperson forthe Lymphoma Research Foundation. Both actresses have recordeda series of informative public service radio announcements aboutthe disease.

The Lymphoma Research Foundation of America was organized in 1991to raise funds to support research projects seeking to cure lymphomaand find better, safer treatments. To date, 32 research grantshave been awarded.

Internet Site

The Lymphoma Research Foundation also sponsors lymphoma supportgroups, provides programs and resource referrals for patients,publishes a newsletter, and maintains an informative site on theInternet that can be reached at: http://www.lymphoma.org.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content